Search
for
Sort by
Research 31–60 of 1000+
- Co-Relation Between Androgenetic Alopecia and Severity of COVID-19 Disease – A Cross-Sectional Study
- 15 Evaluation of several hematological and inflammatory parameters in patients with alopecia areata and their correlation with disease severity
- Association Between Oxidative Stress Biomarkers And Clinical Severity Of Alopecia Areata: A Systematic Review
- Serum Epidermal Growth Factor Level and its Relation to Severity of Alopecia Areata
- Efficacy of Baricitinib in Patients with Various Degrees of Alopecia Areata Severity: Post-Hoc Analysis from BRAVE AA1 and BRAVE AA2
- Serum IL-21 Level and Its Relation to Activity and Severity of Alopecia Areata
- PD-1+CXCR5−CD4+T cells are correlated with the severity of systemic lupus erythematosus
- Cellular retinol‐binding protein‐1 expression increases with increasing clinical severity of alopecia areata
- Differential expression of steroid 5α-reductase isozymes and association with disease severity and angiogenic genes predict their biological role in prostate cancer
- Serum androgen levels and their relationship to pattern and severity of hair growth in hirsute women presenting at private centre in Hyderabad
- Quantitative evaluation of carcinosin as an individualized remedy in pediatric alopecia areata using salt score and ludwig hair loss scales: A case report
- Demographic Features, Clinical Factors and Severity of Disease among Patients with Alopecia Areata
- Serum 25-Hydroxy Vitamin D Level in Patients with Alopecia Areata and Its Relationship with Severity of the Disease
- Long-term dutasteride therapy in men with benign prostatic hyperplasia alters glucose and lipid profiles and increases severity of erectile dysfunction
- Free Testosterone Levels in Patients with Covid-19 and its Association with Disease Severity
- Evaluation of neutrophil to lymphocyte ratio, platelet to lymphocyte ratio, mean platelet volume, CRP and ESR with disease severity in patients with alopecia areata
- Serum level of retinol-binding protein 4 in alopecia areata: relation with recurrence and severity
- Current Diagnostic and Therapeutic Practices in Alopecia Areata in Two Mediterranean Countries: A Survey-Based Study
- Epidemiology, Diagnosis and Management of Alopecia Areata: An Asia‐Pacific Modified Delphi Expert Panel Recommendations
- Effectiveness of Tofacitinib in Pre-adolescent Alopecia Areata: A Retrospective Case Series and Literature Review
- Efficacy, safety and dose response of STS01, a topical controlled release nanoparticle formulation (dithranol/Prosilic), in adults with mild to moderate patchy alopecia areata: A randomised, double-blind, multicentre, phase 2 trial
- Tofacitinib for the treatment of severe alopecia areata and variants: A study of 90 patients
- Safety and efficacy of the JAK inhibitor tofacitinib citrate in patients with alopecia areata
- An Open-Label Pilot Study to Evaluate the Efficacy of Tofacitinib in Moderate to Severe Patch-Type Alopecia Areata, Totalis, and Universalis
- Efficacy and safety of the oral Janus kinase inhibitor baricitinib in the treatment of adults with alopecia areata: Phase 2 results from a randomized controlled study
- Topical 2% tofacitinib for children with alopecia areata, alopecia totalis, and alopecia universalis
- Experience with oral tofacitinib in 8 adolescent patients with alopecia universalis
- Objective outcome measures: Collecting meaningful data on alopecia areata
- Ritlecitinib and brepocitinib demonstrate significant improvement in scalp alopecia areata biomarkers
- Effectiveness and safety of baricitinib in patients with severe alopecia areata: a 36-week multicenter real-world experience